SCHEMBL7002207

SCHEMBL7002207

CCCCOC(=O)N1CCC(C)(C(=O)OCc2ccccc2)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.53
▸ CYP3A4 P08684 1/20 0.53
▸ TSHR P16473 1/20 0.53
▸ MAPK1 P28482 1/20 0.53
▸ TDP1 Q9NUW8 1/20 0.53
▸ L3MBTL1 Q9Y468 1/20 0.53
▸ OPRD1 P41143 2/20 0.52
▸ OPRK1 P41145 1/20 0.52
▸ MEN1 O00255 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47
▸ SMN1; SMN2 Q16637 3/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ ENPP2 Q13822 1/20 0.45
▸ ATXN2 Q99700 1/20 0.45
▸ CCR5 P51681 2/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ POLB P06746 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL629912 0.85 MEN1 (0.54) ALDH1A1TSHRL3MBTL1OPRD1OPRK1
SCHEMBL7299227 0.85 L3MBTL1 (0.59) ALDH1A1CYP3A4TSHRMAPK1TDP1
SCHEMBL3558511 0.82 ALDH1A1 (0.46) ALDH1A1MEN1KMT2ANPSR1SMN1; SMN2
SCHEMBL29365580 0.82 SMN1; SMN2 (0.56) ALDH1A1OPRD1OPRK1MEN1KMT2A
SCHEMBL630859 0.81 MEN1 (0.50) ALDH1A1TSHRL3MBTL1MEN1KMT2A
SCHEMBL25670728 0.81 CYP2D6 (0.53) ALDH1A1MEN1KMT2ARAB9A
SCHEMBL3104656 0.81 MEN1 (0.50) TSHROPRD1OPRK1MEN1KMT2A
SCHEMBL25302503 0.81 OPRD1 (0.48) ALDH1A1CYP3A4TSHRMAPK1TDP1
SCHEMBL3556103 0.80 CYP2C19 (0.47) ALDH1A1MEN1KMT2ANPSR1SMN1; SMN2
SCHEMBL631455 0.80 MEN1 (0.59) ALDH1A1L3MBTL1OPRD1OPRK1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165540-B1 TETRAHYDROPYRAN DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS MERCK SHARP & DOHME (GB) 2003-08-13 — — EP disclosed
US-6458830-B1 THE COMPOUNDS ARE OF PARTICULAR USE IN THE TREATMENT OR PREVENTION OF DEPRESSION, ANXIETY, PAIN, INFLAMMATION, MIGRAINE, EMESIS AND POSTHERPETIC NEURALGIA. MERCK SHARP & DOHME LTD. 2002-10-01 — — US disclosed
CN-1344264-A Tetrahydropyran derivatives and their use as therapeutic agents MERCK SHARP & DOHME (GB) 2002-04-10 — — CN disclosed
EP-1165540-A1 TETRAHYDROPYRAN DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS MERCK SHARP & DOHME LTD. (GB) 2002-01-02 — — EP disclosed
WO-2000056727-A1 TETRAHYDROPYRAN DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS MERCK SHARP & DOHME LIMITED (GB) 2000-09-28 — — WO disclosed
WO-2000056728-A1 TETRAHYDROPYRAN DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS MERCK SHARP & DOHME LIMITED (GB) 2000-09-28 — — WO disclosed
Send feedback